The Nebraska Medical Center Biologics Production Facility

The Nebraska Medical Center Biologics Production Facility – The Nebraska Medical Center’s Biologics Production Facility is designed to support scientific and clinical investigators in developing and testing the most promising new medical therapies with the goal of improving cancer treatments and other difficult to treat diseases using the most modern medicine techniques. With a reputation for cutting-edge research and treatment, The Nebraska Medical Center is home to the region’s largest Biologics Production Facility. The 20000 square foot facility is designed to support scientific and clinical investigators in developing and testing the most promising new medical therapies through the manufacturing, production and modification of cells, tissues, cellular and tissue-derived products. The facility provides an important venue for researchers to transition small scale basic science research to the bedside through phase I and II clinical trials. The Nebraska Medical Center has had a long history of achievement in developing treatments for cancer and other diseases through the transplantation of cellular and tissue-based products, including bone marrow and stem cells, as well as solid organs. The Biologics Production Facility allows The Nebraska Medical Center to increase its capabilities in these areas as well as other areas of therapeutic medicine with the goal of improving cancer treatments and other difficult to treat diseases using the most modern medicine techniques. About the facility The Biologics Production Facility meets Good …

Monkey Study Suggests Long-Term ADHD Drug Use Appears Safe

Filed under: Drug Treatment Centers Nebraska

Between 5 to 7 percent of elementary school children are diagnosed with ADHD, according to researchers from the Wake Forest Baptist Medical Center who undertook the new study. Many of these children are treated with psychostimulant drugs, and while …
Read more on PsychCentral.com

Alzheimer's drug fails in 1 study, 2nd continues

Filed under: Drug Treatment Centers Nebraska

TRENTON, N.J. — A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the road for the drug. Pfizer Inc. said Monday that it will …
Read more on Macon Telegraph (blog)